81 related articles for article (PubMed ID: 2509605)
1. [Combination therapy of renal cell carcinoma with interferon-alpha and UFT (or FT-207)].
Kobayashi M; Imai K; Yamanaka H; Takahashi H; Mashimo T; Shimizu N; Koya J; Yajima H; Kawashima K; Kitaura K
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1437-46. PubMed ID: 2509605
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of renal cell carcinoma. 3. Interferon therapy].
Kobayashi M; Imai K; Kiren H; Nakai K; Saruki K; Umeyama T; Ito Y; Yamanaka H; Makino T; Machida M
Hinyokika Kiyo; 1987 Apr; 33(4):508-14. PubMed ID: 3618421
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of renal cell carcinoma].
Yamada Y; Fukatsu H; Honda N; Miyagawa Y; Segawa A
Hinyokika Kiyo; 1993 Dec; 39(12):1197-203. PubMed ID: 7506869
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Yamada Y; Muramatsu T; Honda N; Fukatsu H; Segawa A; Hirata N; Senda H
Hinyokika Kiyo; 1990 May; 36(5):527-34. PubMed ID: 2119093
[TBL] [Abstract][Full Text] [Related]
5. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Kanno H; Kitami K; Senga Y; Takahashi T; Nagashima Y
Hinyokika Kiyo; 1993 Aug; 39(8):725-9. PubMed ID: 8379474
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of UFT in renal cell carcinoma].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508
[TBL] [Abstract][Full Text] [Related]
7. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
Figlin RA; deKernion JB; Maldazys J; Sarna G
Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
[TBL] [Abstract][Full Text] [Related]
8. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Niijima T; Akaza H; Koyanagi T; Togashi M; Kumamoto Y; Funyu T; Suzuki T; Orikasa S; Yoshikawa K; Koiso K
Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
[TBL] [Abstract][Full Text] [Related]
9. [Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Terachi T; Okada Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1993 Apr; 39(4):353-5. PubMed ID: 8503332
[TBL] [Abstract][Full Text] [Related]
10. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
[TBL] [Abstract][Full Text] [Related]
11. [Effects of UFT in advanced renal cell cancer].
Koseki K; Akaza H; Kishi H; Umeda T; Isurugi K; Niijima T
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2061-4. PubMed ID: 3931562
[TBL] [Abstract][Full Text] [Related]
12. [Therapy on pulmonary metastasis of renal cell carcinoma].
Hara M; Kawamura N; Hasegawa J; Akimoto M
Hinyokika Kiyo; 1990 Oct; 36(10):1125-9. PubMed ID: 2148250
[TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Yanase I; Shirahama T; Kayajima T; Ohi Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):709-12. PubMed ID: 3128184
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Ryan CW; Vogelzang NJ; Dumas MC; Kuzel T; Stadler WM
Cancer; 2000 Mar; 88(6):1317-24. PubMed ID: 10717612
[TBL] [Abstract][Full Text] [Related]
15. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of UFT in advanced renal cell carcinoma].
Hoshino M; Inoue K; Higaki M; Imamura K
Hinyokika Kiyo; 1988 Mar; 34(3):538-40. PubMed ID: 3133935
[TBL] [Abstract][Full Text] [Related]
17. [Histopathologic evaluation of anti-tumor activity of alpha-interferon for renal cell carcinoma, especially in autoptic cases].
Yamauchi T; Kawamura J; Yoshida O; Fukuyama T; Ogura K; Nakagawa K
Hinyokika Kiyo; 1985 Sep; 31(9):1539-52. PubMed ID: 4083212
[TBL] [Abstract][Full Text] [Related]
18. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
19. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]